The MIT xPRO Drug and Medical Device Development: A Strategic Approach program explores the entire process of identifying the benefits and risks—and the strategic choices made along the way—of bringing a new medical product to market. This program provides the “big picture” perspective of medical product development, while delving into those details that will help you avoid the major pitfalls that ensnare market incumbents and startups alike.

MIT xPRO's Artificial Intelligence in Healthcare program is designed to equip you with the skills to broaden your understanding of the applications of AI-based technologies in healthcare.

This course is self-paced. Enroll at any time. No weekly assignments. By the end of this course, you will understand how decisions made as early as product discovery can impact how a biologic is manufactured and delivered.